Ardelyx, Inc. (ARDX)
$3.74-3.86%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $924M
- Avg volume
- 4.1M
- Beta
- 0.73
- P/E (TTM)
- -16.57
- Short % float
- 11.06%
- Days to cover
- 11.0
- SI change
- -0.0%
- 1W
- -7.88%
- 1M
- -25.65%
- 3M
- -38.79%
- YTD
- -39.19%
- vs SPY 1W
- -6.69%
- vs SPY 1M
- -28.97%
- vs SPY 3M
- -41.18%
- vs SPY YTD
- -50.94%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- GLSIBUYGreenwich LifeSciences, Inc.RECOVERYQ 27$17.58+5.46%
- MDGLSELLMadrigal Pharmaceuticals, Inc.RECOVERYQ 16$511.97-0.92%
- PHIOBUYPhio Pharmaceuticals Corp.RECOVERYQ 3$1.17-0.85%
- APUSSELLApimeds Pharmaceuticals US, IncCRISISQ -26$4.75-1.86%
- VNDABUYVanda Pharmaceuticals Inc.RECOVERYQ 13$5.33+0.95%
- BLTEBUYBelite Bio, IncRECOVERYQ 54$158.87-1.36%
- CELCSELLCelcuity Inc.RECOVERYQ 29$90.79-2.93%
- DMRABUYGalecto, Inc.RECOVERYQ -3$30.31-1.65%
- ZURABUYZura Bio LimitedRECOVERYQ 13$6.30+7.69%
- ENVBSELLEnveric Biosciences, Inc.CRISISQ -8$1.41-1.40%
- ORGOSELLOrganogenesis Holdings Inc.CRISISQ 5$1.67-7.22%
- XFORBUYX4 Pharmaceuticals, Inc.RECOVERYQ -12$4.05+0.25%
Industry peers
FMP comparable companies · ranked by market cap
- SYREBUYSpyre Therapeutics, Inc.$9.2BBULLQ 11$106.49+0.15%
- TRVIBUYTrevi Therapeutics, Inc.$2.5BBULLQ 22$17.96+0.67%
- PHVSBUYPharvaris N.V.$2.5BBULLQ 17$36.27+2.87%
- BCRXBUYBioCryst Pharmaceuticals, Inc.$2.4BRECOVERYQ 6$9.55+1.36%
- ZYMEBUYZymeworks Inc.$2.1BRECOVERYQ 13$28.67+0.35%
- STOKBUYStoke Therapeutics, Inc.$2.1BRECOVERYQ 13$32.29+0.09%
- NTLABUYIntellia Therapeutics, Inc.$1.8BRECOVERYQ 3$12.84-2.18%
- MAZESELLMaze Therapeutics, Inc.$1.6BRECOVERYQ 40$29.43+0.58%
- WVESELLWave Life Sciences Ltd.$1.0BCRISISQ 9$5.29-3.21%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 15
- VALUE
- 3
- GROWTH
- 40
- GARP
- 1
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-21.6%
REV YoY-
ROE-36.0%
EPS YoY-
ROA-9.7%
GROSS94
OP-8
NET-12
[VALUATION]
P/E TTM-16.57
P/E FWD-
SECTOR PE22.66
INDUSTRY PE17.07
P/B6.23
P/FCF-
EV/EBITDA-45.54
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E171.92
ALTMAN Z-
CURR RATIO3.34
ND/EBITDA-
BETA0.73
